UFC women’s strawweight title challenger Valerie Letourneau has been drug tested in advance of her fight with Joanna Jedrzejczyk at UFC 193, according to the U.S. Anti-Doping Agency’s athlete test history.

UFC 193, which features Jedrzejczyk (10-0 MMA, 4-0 UFC) vs. Letourneau (8-3 MMA, 3-0 UFC) in the pay-per-view co-headliner, takes place Nov. 14 at Etihad Stadium in Melbourne.

Letourneau is among six UFC fighters who’ve been tested a total of nine times by USADA in the fourth quarter of this year. Half of those fighters are scheduled for fights; an injury scratched a heavyweight bout between Stipe Miocic (13-2 MMA, 7-2 UFC) and Ben Rothwell (35-9 MMA, 5-3 UFC) at Saturday’s UFC Fight Night 76 in Dublin.

Additionally, UFC heavyweight Todd Duffee (9-3 MMA, 3-2 UFC), whom Frank Mir (18-9 MMA, 16-9 UFC) knocked out in July, was tested twice, bringing one him closer to the most visited athlete on the UFC’s roster: UFC 193 headliner women’s bantamweight champ Ronda Rousey, who’s been tested five times. Duffee once held a therapeutic-use exemption in the state of Nevada to use the now-banned testosterone-replacement therapy.

With two months left in the fourth quarter and nine UFC events scheduled before the end of the year, many more tests are expected by the UFC’s anti-doping partner, which implemented a new drug-testing program in July.

The full list of fighters includes:

Junior Dos Santos 2 Todd Duffee 2 Dan Henderson 2 Valerie Letourneau 1 Stipe Miocic 1 Ben Rothwell 1

For more on UFC 193, check out the UFC Rumors section of the site.